Medicare Advantage in 2026: Enrollment Update and Key Trends
(Authors: Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Jun 5, 2026)
Read More
Part D/Prescription Drugs
Eli Lilly’s 340B deadline passes: What hospitals should know
(By: Ella Jeffries for Becker’s Hospital Review) Eli Lilly’s deadline for hospitals to submit claims data or lose 340B drug
Read MoreMedicare Advantage in 2026: Premiums, Out-of-Pocket Limits, Supplemental Benefits, and Prior Authorization
(Authors: Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Jun 5, 2026)
Read More
CMS Medicare fines keep coming: 5 recent updates
(By: Jakob Emerson for Becker’s Hospital Review) CMS has issued dozens of fines against Medicare Advantage, Part D and special
Read More
What IRMAA actually does to your check
IRMAA (Income-Related Monthly Adjustment Amount) is a surcharge on Medicare Part B and Part D premiums for high-income beneficiaries. The
Read More
GLP-1s in Medicare and Medicaid: Access alone is not a care model
(Pankhuri Sharma, Humana for Becker’s Hospital Review) The clinical value of GLP-1 receptor agonists is now well established. Multiple trials
Read More
Part B premium hike isn’t the only added cost seniors are dealing with in 2026
On November 14, 2025, the Centers for Medicare & Medicaid Services (CMS) announced the Part B premiums for 2026. The
Read MoreMedicare Advantage Out-of-Pocket Limits: Variation and Trends
(Authors: Nancy Ochieng, Meredith Freed, Jeannie Fuglesten Biniek, Juliette Cubanski, and Tricia Neuman for The Kaiser Family Foundation Published: May
Read More
Changes to Medicare Advantage in 2027
The Centers for Medicare & Medicaid Services finalized changes to Medicare Advantage and Medicare Part D. The majority of these
Read More
Health systems sue CVS over alleged $250M 340B scheme
(By: Alan Condon for Becker’s Hospital Review) Three health systems have filed federal lawsuits against CVS Health, alleging the company
Read More